Issues concerning feedback about genetic testing and risk of depression

British Journal of Psychiatry

Volumn 194, Issue 5, 2009, Pages 404-410

  Wilhelm, Kay ^a,c   Meiser, Bettina ^b   Mitchell, Philip B ^a   Finch, Adam W ^a   Siegel, Jennifer E ^a   Parker, Gordon ^a   Schofield, Peter R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; ALLELE; ARTICLE; DEPRESSION; DISTRESS SYNDROME; FEMALE; FOLLOW UP; GENE ENVIRONMENT INTERACTION; GENE INTERACTION; GENETIC PROCEDURES; GENOTYPE; HUMAN; MALE; MOLECULAR GENETICS; RISK; ADOLESCENT; ATTITUDE TO HEALTH; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MIDDLE AGED; NONPARAMETRIC TEST; ONSET AGE; PATIENT RIGHT; PSYCHOLOGICAL ASPECT; STATISTICS;

ADOLESCENT; ADULT; AGE OF ONSET; ATTITUDE TO HEALTH; COHORT STUDIES; DEPRESSIVE DISORDER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCESS TO RECORDS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 67649347935     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.107.047514     Document Type: Article

References (42)

1. Meiser B. Psychological impact of genetic testing for cancer susceptibility. An update of the literature. Psychooncology 2005; 14: 1060-74.
2. Meiser B, Dunn SM. Psychological impact of genetic testing for Huntington disease. An update of the literature for clinicians. J Neurol Neurosurg Psychiatry 2000; 69: 574-8.
3. Lerman C, Shields AE. Genetic testing for cancer susceptibility: the promise and the pitfalls. Wat Rev Cancer 2004; 4: 235-41.
4. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression. Moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386-9.
5. Eley T, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, et al. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004; 9: 908-15.
6. Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, et al. I. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 2005; 10: 220-4.
7. Kaufman J, Yang BZ, Douglas-Palumberi H, Houshyar S, Lipschitz D, Krystal JH, et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad sci USA 2004; 101:17316-21.
8. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression. Arch Gen Psychiatry 2005; 62: 529-35.
9. Sjoberg RL, Nilsson KW, Nordquist N, Ohrvik J, Leppert J, Linstrom L, et al. Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. Int J Neuropsychopharmacol 2006; 9: 1-7.
10. Wilhelm K, Mitchell PB, Niven H, Finch A, Wedgwood L, Scimone A, et al. Life events, first depression onset and the serotonin transporter gene. BrJ Psychiatry 2006; 188: 210-5.
11. Cervilla JA, Molina E, Rivera M, Torres-Gonzalez F, Bellon JA, Moreno B, et al. The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype: evidence from the Spanish PREDICT-Gene cohort. Mol Psychiatry 2007; 12: 748-55.
12. Gillespie NA, Whitfield JB, Williams B, Heath AC, Martin NG. The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med 2005; 35: 101-11.
13. Surtees PG, Wainwright NW, Willis-Owen SA, Luben R, Day NE, Flint J, et al. Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol Psychiatry 2006; 59: 224-9.
14. Lenze EJ, Munin MC, skidmore ER, Dew MA, Rogers JC, Whyte EM, et al. Onset of depression in elderly persons after hip fracture. Implications for prevention and early intervention of late-life depression. J Am Geriatr Soc 2007; 55: 81-6.
15. Nakatani D, Sato H, Sakata Y, Shiotani Y, Kinjo K, Mizuno H, et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 2005; 159: 652-8.
16. Wilhelm K, Parker G, Ashari A. Sex differences in the experience of depressed mood state over fifteen years. Soc Psychiatry Psychiatr Epidemiol 1998; 33: 16-20.
17. Robins L, Helzer J. New diagnostic instruments. In Handbook of Social Psychiatry (ed G Burrows): 3-12. Elsevier, 1988.
18. Watson D, Clark A, Tellegen, A. Development and validation of brief measures of positive and negative affect. J Pers Soc Psychol 1988; 54: 1063-70.
19. Meiser B, Mitchell P, McGirr H, Van Herten M, Schofield, P. Implications of genetic risk information in families with a high density of bipolar disorder. An exploratory study. soc Sci Med 2005; 60: 109-18.
20. Meiser B, Kasparian N, Mitchell P, Strong K, Simpson J, Tabassum L, et al. Attitudes to genetic testing in families with multiple cases of bipolar disorder. Genet Test 2008; 12: 233-43.
21. Cella D, Chang C, Peterman A, Wenzel L, Marcus A, Hughes C, et al. A brief assessment of concerns associated with genetic testing for cancer. The multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychol 2002; 21: 564-72.
22. Hothorn T, Hornik K, van de wiel M, Zeileis A. Coin: conditional inference procedures in a permutation test framework, R package, version 0.6-0.7. CRAN, 2007 (http://CRAN.R-project.org).
23. Jones I, Scourfield J, McCandless F, Craddock N. Attitudes towards future testing for bipolar disorder susceptibility genes. A preliminary investigation. J Affect Disord 2002; 71: 189-93.
24. Smith LB, Sapers B, Reus VI, Freimer NB. Attitudes towards bipolar disorder and predictive testing among patients and providers. J Med Genet 1996; 33: 544-9.
25. Trippitelli CL, Jamison KR, Folstein MF, Bartko JJ, DePaulo JR. Pilot study on patients' and spouses' attitudes toward potential genetic testing for bipolar disorder. Am J Psychiatry 1998; 155: 899-904.
26. Austin J, Smith G, Honer w. The Genomic ear and perceptions of psychotic disorders. Genetic risk estimation, associations with reproductive decisions and views about predictive testing. Am J Med Genet Part B 2006; 141B: 926-8.
27. DeUsi L, Bertisch H. A preliminary comparision of the type of researchers, clinicians and families for the future ethical use of genetic findings on schizophrenia. Am J Med Genet Part B 2006; 141B: 110-5.
28. Laegsgaard M, Mors 0. Psychiatric genetic testing. Attitudes and intentions among future users and providers. Am J Med Genet Part B 2007; 147B: 375-84.
29. Illes F, Rietz C, Fuchs M, Ohiraun S, Prell K, Rudinger G, et al. Einstellung zu psychiatrisch-genetischer Forschung und pradiktiver Diagnostik: Hoffnungen und Befurchtungen von Patienten, Angehb'rigen und der Allgemeinbevoikerung in Deutschland (Attitudes towards psychiatric genetic research and predictive testing: hopes and fears of patients, relatives and the general population in Germany]. Ethik in der Medizin 2003; 15: 268-81.
30. Lerman C, Croyle R, Tercyak K, Hamann H. Genetic testing: psychological aspects and implications. J Consult Clin Psychol 2002; 70: 784-97.
31. Harper PS, Lim C, David C. Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium. J Med Genet 2000; 37: 567-71.
32. weissman M, Bland R, Canino G, Faravelli C, Greenwald S, Hwu H, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996; 276: 293-9.
33. Wilhelm K, Parker G, Dewhurst-Savellis J, Asghari A. Psychological predictors of single and recurrent major depressive episodes. J Affect Disord 1999; 54: 139-47.
34. Wilhelm K, Parker G, Hadzi-Pavlovic D. Fifteen years on: evolving ideas on researching sex differences in depression. Psychol Med 1997; 27: 875-83.
35. Mastromauro C, Myers RH, Berkman B. Attitudes toward presymptomatic testing in Huntington's disease. Am J Med Genet 1987; 26: 271-82.
36. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA 1996; 275: 1885-92.
37. Harper PS. What do we mean by genetic testing? J Med Genet 1997; 34: 749-52.
38. Harper PS, Clarke A. Should we test children for 'adult' genetic diseases? Lancet 1990; 335:1205-6.
39. Shields A, Lerman C, Sullivan PF. Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations. Nicotine Tob Res 2004; 6: 675-88.
40. Westbrook MT, Legge V, Pennay M. Attitudes towards disability in a multicultural society. Soc Sci Med 1993; 36: 615-23.
41. Wilhelm K, Siegel JE, Finch AW, Hadzi-Pavlovic D, Mitchell PB, Parker G, et al. The long and the short of it: associations between 5-HTT genotypes and coping with stress. Psychosom Med 2007; 69: 614-20.
42. Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, et al. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005; 62: 146-52.